Literature DB >> 17938616

Proximal embolic protection with aspiration in percutaneous coronary intervention using the Proxis device.

Karel T Koch1, Joost D E Haeck, René J Van Der Schaaf, Frazil M Alidjan, José P S Henriques, Jan Baan, Jan J Piek, Allard C Van Der Wal, Jan G P Tijssen, Gabor Sütsch, Robbert J De Winter.   

Abstract

Distal embolization during primary percutaneous coronary intervention (PCI) occurs in at least 15% of patients and is a strong predictor of more extensive myocardial damage and a poor prognosis. Several devices are designed to evacuate the intracoronary thrombus or to prevent distal embolization. The Proxis device is a proximal embolic protection system that completely blocks antegrade flow during PCI. It may prevent distal embolization during recanalization of thrombotic coronary occlusion and thus improve outcome. We created a registry of 172 patients with ST-segment elevation myocardial infarction who underwent primary PCI with proximal embolic protection and aspiration. The mean ST-segment elevation resolution (STR) at 1 hour was 77.7%+/- 15.2; STR was greater than 50% in 94% and greater than 70% in 72% of patients. The 1-year cumulative major adverse cardiac and cerebrovascular events rate was 10.5%. The overall mortality at 1 year was 2.3%.

Entities:  

Mesh:

Year:  2007        PMID: 17938616

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  4 in total

Review 1.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

2.  A multifaceted approach to intracoronary thrombus: Use of pharmacology, an aspiration catheter and an embolic protection device.

Authors:  W Keeble; R Welsh
Journal:  Can J Cardiol       Date:  2009-11       Impact factor: 5.223

3.  Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial.

Authors:  J D E Haeck; K T Koch; Y L Gu; L Bilodeau; W J Kuijt; K D Sjauw; J P S Henriques; J Baan; M M Vis; N J W Verouden; M Groenink; J J Piek; J G P Tijssen; M W Krucoff; F Zijlstra; R J de Winter
Journal:  Neth Heart J       Date:  2010-11       Impact factor: 2.380

4.  Histopathological features of aspirated thrombi after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.

Authors:  Miranda C Kramer; Allard C van der Wal; Karel T Koch; Saskia Z Rittersma; Xiaofei Li; Hanneke P Ploegmakers; José P Henriques; René J van der Schaaf; Jan Baan; Marije M Vis; Martin G Meesterman; Jan J Piek; Jan G Tijssen; Robbert J de Winter
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.